Literature DB >> 28760027

Clinical and radiological outcomes of spinal endoscopic discectomy-assisted oblique lumbar interbody fusion: preliminary results.

Dong Hwa Heo1, Jin-Sung Kim2.   

Abstract

OBJECTIVE Direct neural decompression cannot be achieved by performing lateral lumbar interbody fusion (LLIF). To overcome the indirect decompressive effect of LLIF, additional endoscopic discectomy with oblique lumbar interbody fusion (OLIF) has been attempted. The purpose of this study was to assess the clinical and radiological outcomes of patients who underwent OLIF with additional endoscopic discectomy. METHODS Spinal endoscopic discectomy-assisted OLIF was attempted to remove herniated disc material. Only patients with a follow-up time that exceeded 12 months were enrolled. Clinical parameters examined were the Oswestry Disability Index and visual analog scale scores of back and leg pain. Postoperative MRI was also performed. RESULTS Fourteen patients were enrolled. Central and foraminal disc herniations were evident in 8 and 6 patients, respectively. Concomitant central or foraminal herniated discs were removed completely after additional endoscopic discectomy, and disc removal was confirmed by postoperative MRI. Mean preoperative visual analog scale scores and Oswestry Disability Index scores improved postoperatively. CONCLUSIONS OLIF with additional endoscopic discectomy results in successful direct neural decompression without posterior decompressive procedures. Endoscopic assistance might overcome the limitations of LLIF.

Entities:  

Keywords:  ALIF = anterior lumbar interbody fusion; DLIF = direct lateral interbody fusion; LLIF = lateral lumbar interbody fusion; ODI = Oswestry Disability Index; OLIF = oblique lumbar interbody fusion; TLIF = transforaminal lumbar interbody fusion; discectomy; endoscopy; lumbar disc disease; oblique lumbar interbody fusion; stenosis

Mesh:

Year:  2017        PMID: 28760027     DOI: 10.3171/2017.5.FOCUS17196

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  7 in total

1.  Learning Curve and Complications Experience of Oblique Lateral Interbody Fusion : A Single-Center 143 Consecutive Cases.

Authors:  Bu Kwang Oh; Dong Wuk Son; Su Hun Lee; Jun Seok Lee; Soon Ki Sung; Sang Weon Lee; Geun Sung Song
Journal:  J Korean Neurosurg Soc       Date:  2021-04-30

2.  Differences in radiographic and clinical outcomes of oblique lateral interbody fusion and lateral lumbar interbody fusion for degenerative lumbar disease: a meta-analysis.

Authors:  Hui-Min Li; Ren-Jie Zhang; Cai-Liang Shen
Journal:  BMC Musculoskelet Disord       Date:  2019-12-04       Impact factor: 2.362

3.  Learning Curve and Clinical Outcome of Biportal Endoscopic-Assisted Lumbar Interbody Fusion.

Authors:  Ju-Eun Kim; Hyun-Seung Yoo; Dae-Jung Choi; Jin-Ho Hwang; Eugene J Park; Seungho Chung
Journal:  Biomed Res Int       Date:  2020-12-17       Impact factor: 3.411

4.  Introducing V-Line as a New Strategy to Choose Surgical Corridor in Oblique Lumbar Interbody Fusion at the L5-S1 Segment.

Authors:  Wei Zhang; Xing Du; Yong Zhu; Wei Luo; Ben Wang; Guanyin Jiang; Yunsheng Ou
Journal:  Dis Markers       Date:  2021-04-22       Impact factor: 3.434

Review 5.  Endoscopic Techniques for Lumbar Interbody Fusion: Principles and Context.

Authors:  Bryan Zheng; Elias Shaaya; Josh Feler; Owen P Leary; Matthew J Hagan; Ankush Bajaj; Jared S Fridley; Frank Hassel; Raymond Gardocki; Ricardo Casal Grau; Kai-Uwe Lewandrowski; Albert E Telfeian
Journal:  Biomed Res Int       Date:  2022-03-19       Impact factor: 3.411

6.  Clinical Outcomes of Biportal Endoscopic Interlaminar Decompression with Oblique Lumbar Interbody Fusion (OLIF): Comparative Analysis with TLIF.

Authors:  Ho-Jin Lee; Eugene J Park; Jae-Sung Ahn; Sang Bum Kim; Youk-Sang Kwon; Young-Cheol Park
Journal:  Brain Sci       Date:  2021-05-13

Review 7.  Intervertebral Disc Diseases PART 2: A Review of the Current Diagnostic and Treatment Strategies for Intervertebral Disc Disease.

Authors:  Pang Hung Wu; Hyeun Sung Kim; Il-Tae Jang
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.